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Abstract
Introduction: Our objective was to determine the frequency of and factors associated with prevalent vertebral
compression fractures in female systemic lupus erythematosus (SLE) patients attending rheumatologists in western
Sweden.
Methods: In this cross sectional study 150 women were included. They were examined with x-ray of thoracic and
lumbar spine (Th4 to L4). A reduction of at least 20% of any vertebral height, assessed by Genant’s
semiquantitative method, was defined as a fracture. Bone mineral density (BMD) was measured by dual energy
x-ray absorptiometry (DXA).
Results: Median patient age was 47 years (20 to 82) and disease duration 11 years (1 to 41). Only 6 (4%) women
had a history of clinical compressions whereas 43 (29%) had at least one radiological fracture each. The patients
with at least one fracture at any site were characterized by older age (P < 0.001), being postmenopausal (P < 0.01),
higher Systemic Lupus International Collaborative Clinics Damage Index (P < 0.05), lower BMD total hip and
femoral neck (P < 0.05), more peripheral fractures (P < 0.01), medication with bisphosphonates (P <0.05) and
calcium and vitamin D3 (P < 0.05). There were no significant differences regarding current or cumulative
glucocorticosteroid dose between the groups. In logistic regression analyses high age remained as a risk factor of
at least one vertebral fracture at any site whereas low BMD in total hip was associated with vertebral fracture in
the lumbar spine.
Conclusions: Radiological compression fractures are common but seldom diagnosed in SLE patients. High age and
low BMD in total hip, but not in spine, was associated with vertebral fractures.
Introduction
With improved treatment, long term morbidity like car-
diovascular disease and fractures become increasingly
important in managing systemic lupus erythematosus
(SLE). Several studies have shown increased risk for per-
ipheral as well as vertebral fractures in SLE patients
compared to the general population [1-3]. Peripheral
fractures are often easy to diagnose whereas vertebral
compression fractures can be clinically silent [4] or be
recognized as ordinary back pain by the patient and
therefore overlooked [5]. Glucocorticosteroids, often
used in the treatment of SLE, may not only increase the
loss of bone [6] but also influence vertebral strength by
affecting bone cell survival [7].
Low bone mineral density (BMD) is a known risk fac-
tor of fracture [8]. Since several other risk factors are
hard to influence, much effort is given to find and phar-
macologically treat patients with low BMD. SLE patients
often have other concurrent risk factors of low BMD
and fracture like glucocorticosteroid medication, early
menopause [9,10] and sun avoidance with possible vita-
min D deficiency [11,12]. Recent studies have shown
that vertebral compression fractures are common in SLE
patients in spite of normal BMD [2,13] indicating alter-
native mechanisms to the origin of compression frac-
tures. It also points to the necessity of radiological
examination in finding compressions of the spine.
The aim of this study was to establish the prevalence
of clinically reported and radiological verified vertebral
compression fractures in female SLE patients in western
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ciated with these fractures.
Material and methods
Patients
All patients with SLE attending the rheumatology clinics
in Göteborg and Borås, Sweden, were identified from
administrative registers and invited to participate in this
cross-sectional study. The procedure of enrolment has
previously been described in detail [14]. In short, 339
patients, 298 women and 41 men, were identified. There
was a 70% reply frequency among the female patients.
The main reason for women not to participate were not
wanting or not being able to participate (n =3 0 )a n d
not meeting the inclusion criteria of at least four of the
1982 American College of Rheumatology (ACR) classifi-
cation criteria for SLE [15] (n = 18). One hundred sixty-
three female patients were included in the study. Thir-
teen were excluded in this analysis because they lacked
radiographs. Data regarding 150 patients were included
and analysed. For each patient data on demographic and
disease related variables like age, duration of disease,
weight and height, medication, dietary calcium intake,
smoking habits, physical activity and clinical fractures
after the age of 25 were assessed by self administered
questionnaires. Both low and high energy peripheral
fractures were reported. Dietary calcium intake was cal-
culated from information on average intake of cheese
and milk. Exercise was recorded as “times per week with
regular physical exercise” and it is therefore possible to
get a median value of zero.
T h eS y s t e m i cL u p u sE r y t h e matosus Disease Activity
Index 2 K (SLEDAI-2K) [16] was used to score disease
activity. Disease damage was recorded according to Sys-
temic Lupus International Collaborative Clinics/Ameri-
can College of Rheumatology Damage Index (DI) [17].
Cumulative corticosteroid intake was calculated by a
thorough reading of all patients medical records. The
same rheumatologist assessed all patients (KA). Glomer-
ular filtration rate (GFR) was predicted using the Cock-
croft and Gault equation [18]. GFR (ml/min) = (140-
age) × weight (kg) × 1.04/S-creatinine(μmol/l).
Assessment of vertebral compression fractures
Each patient underwent two lateral conventional radio-
graphs, one of the thoracic and one of the lumbar spine.
Due to a shift of radiology equipment during the study
period, approximately half of the patients had analog
and the other half had digital radiographs taken. The
same radiologist (SH) evaluated all radiographs for pre-
valent vertebral fractures using Genant’s semiquantita-
tive method [19]. Thirteen vertebrae per patient (Th4 to
L4) were assessable for all patients but one where 11
vertebrae were assessable. In short, the vertebrae were
visually graded as normal (grade 0), mildly deformed
(grade 1, approximately 20 to 29% reduction in anterior,
middle and/or posterior height and a 10 to 20% reduc-
tion in an area), moderately deformed (grade 2, approxi-
mately 30 to 45% reduction of any vertebral height and
a reduction in an area of 20 to 40%), and severely
deformed (grade 3, >45% reduction in any vertebral
height and >40% reduction in an area). For each patient
the number of fractured vertebrae was counted. A ver-
tebral severity sum was calculated by addition of the
Genant grades (0 to 3) from 13 vertebrae for each
patient.
A vertebra was considered fractured when it was
mildly deformed, grade 1.
Laboratory tests
Venous blood samples were taken after a one-night fast
and analysed consecutively using standard laboratory
techniques in the Department of Clinical Chemistry at
Sahlgrenska University Hospital and at Borås Hospital.
Bone mineral density (BMD) measurements
The lumbar spine (L2 to L4), non dominant hip
(femoral neck and total hip) and non dominant distal
forearm were measured by DXA, Lunar Prodigy densit-
ometer, 12165 (GE Medical Systems GE Healthcare,
Little Chalfont, Buckinghamshire, UK). The precisions
for duplicate measurements were 0.9% for the lumbar
spine, 0.5% for the left total hip and femoral neck and
2.8% for the radius.
Ethical aspects
All patients gave informed written consent prior to par-
ticipation and the study was approved by the Ethics
Committee at Sahlgrenska Academy at University of
Gothenburg, Sweden.
Statistical analysis
Analyses were performed using SPSS version 12.0.1
(SPSS Inc., Chicago, IL, USA). Descriptive statistics are
presented as median and range or mean and standard
deviations (SD). All variables in Table 1, including
serum ionized calcium, ESR and CRP, were tested with
Kolmogorov-Smirnov’s normality test. A T-test was
used for comparison of normally distributed demo-
graphic and disease related variables and the Mann-
Whitney U-test was used for not normally distributed
variables between patients with and without vertebral
fractures. A c
2-test was used to compare categorical
variables. Significant variables were then entered in a
logistic regression analyses as covariates and having one
or several vertebral fractures scored 1 to 3 according to
the Genant’s method as dependent variable. A forward
conditional method was used. A receiver operating
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tebral fracture as the state variable. All tests were two-
tailed and P < 0.05 was considered statistically
significant.
Results
Demographic and disease related variables
The SLE patients attending this study did not differ sig-
nificantly in age from those who were invited but did
not participate. The general characteristics of the study
population are shown in Table 1. Fewer than 10 patients
were not Caucasian. The participants’ ages ranged from
20 to 82 years. Sixty-seven (45%) were premenopausal.
Eighty (53%) were on immunosuppressive drugs, 78
(52%) were treated with glucocorticosteroids and 50
(33%) were treated with both immunosuppressive drugs
and glucocorticosteroids. One patient had end-stage
renal disease while 17 (11%) had a calculated glomerular
filtration rate (GFR) less than 40 ml/minute. Nineteen
patients (13%) were treated with thyroid hormones
because of low thyroid function. Thirty-one (21%), 13
(9%) and 9 (6%) of the women had osteoporosis accord-
ing to the definition of WHO [20] in at least one, two
and three or more sites, respectively. Osteoporosis in
the radius total was diagnosed in 22 (15%) of the
patients, in the lumbar spine 16 (11%), in the femoral
neck 11 (7%) and in the total hip 9 (6%). Eleven patients
had substantial vertebral osteoarthritis.
Vertebral fractures
Forty-three women (29%) had at least one and 22 (15%)
had at least two prevalent vertebral compressions each.
Two patients had 10 and 11 compressions each. Thir-
teen (30%) patients with vertebral fracture had active
treatment against osteoporosis, 11 were treated with
bisphosphonates, 1 with hormone replacement therapy
and 1 with selective estrogen receptor modulator ther-
apy. Twenty-nine (67%) patients were medicated with
calcium and vitamin D3. It was not significantly more
common to have at least one vertebral fracture in a
patient with current or former corticosteroid medication
(36/129) as compared to corticosteroid naïve patients
(7/21). Five out of six patients who reported knowledge
of clinical vertebral fracture also had one or several radi-
ological fractures. Thus, 38 (25%) patients had one or
more asymptomatic or not diagnosed fracture. The pro-
portion of patients with prevalent vertebral compres-
sions increased with age but compressions were present
in premenopausal ages as well, Table 2. Mild fractures,
grade 1, were most common and represented 75 (79%)
of all fractures. The fracture prevalence was highest in
mid thoracic spine, Th6 to Th8, whereas compression
severity was highest in lower lumbar spine, Figure 1.
Peripheral fractures
Twenty-two patients (15%) reported a total of 29 clinical
peripheral fractures. There were 13 wrist, 8 ankle,
6 upper arm and 2 hip fractures reported. Seventeen
Table 1 Demographic and disease related variables in
150 female patients with SLE
Demographic variables Value
Patient age (years) 47 (20 to 82)
Weight (kg) 67 (43 to 96)
Height (cm) 166 (145 to 182)
BMI (kg/m2) 24.5 (17.2 to 35.3)
Exercise/week 0 (0 to 7)
Smoking status
Nonsmoker n (%) 59 (39)
Previous smoker n (%) 48 (32)
Current smoker n (%) 43 (29)
Years of smoking, current or previous 24 (0.5 to 48)
Menopausal status
Premenopausal n (%) 67 (45)
Postmenopasal n (%) 81 (55)
Dietary calcium intake (mg/day) 467 (0 to 1,510)
Disease variables
Disease duration (years) 11 (1 to 41)
SLEDAI-2K 5 (0 to 31)
DI 2 (0 to 11)
Haemoglobin (g/l) 131 (80 to 156)
ESR (mm/1 hr) 19 (2 to 125)
CRP (mg/l) 5 (3 to 79)
Creatinine (μmol/l) 88 (49 to 291)
Calcium, ionized (mmol/l) 1.22 (1.07 to 1.42)
Glucocortocosteroid (Prednisolone) user n (%) 78 (52)
Prednisolone dose (mg) 5 (2.5 to 35)
Glucocorticosteroid (Prednisolone) ever user n (%) 129 (86)
Cumulative Prednisolone dose (g) 11 (0.1 to 97.5)
Immunosuppressive drug user n (%) 80 (53)
Calcium and vitamin D n (%) 81 (54)
Bisphosphonates n (%) 21 (14)
Postmenopausal
HRT n (%) 4 (5)
BMD lumbal spine (g/cm
2) mean (SD) 1.12 (0.18)
BMD total hip (g/cm
2) mean (SD) 0.93 (0.14)
BMD femur neck(g/cm
2) mean (SD) 0.89 (0.14)
BMD radius total (g/cm
2) mean (SD) 0.51 (0.08)
Patients with vertebral fracture n (%) 43 (29)
Vertebral fractures/patient 0 (0 to 11)
Sum of Genant’s grading per patient 0 (0 to 22)
Patients with peripheral fracture n (%) 22 (14)
Values are medians and (range) when not indicated otherwise.
BMD, bone mineral density; BMI, body mass index; CRP, C-reactive protein; DI,
Systemic Lupus International Collaborative Clinics/American Collage of
Rheumatology Damage Index; ESR, erythrocyte sedimentation rat; HRT,
hormone replacement therapy; SERM, selective estrogen receptor modulator;
SLEDAI-2K, SLE disease activity index-2K.
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pression fracture had experienced one or several periph-
eral fractures whereas 12 patients (55%) who had
experienced a peripheral fracture also had at least one
compression fracture.
Risk factors of vertebral fractures
Patients with one or more vertebral compressions, grade 1
to 3, were compared with patients without any compres-
sions regarding all demographic and disease related
variables shown in Table 1. Variables significantly asso-
ciated with compression fractures are displayed in Table 3.
Current or cumulative doses of glucocorticosteroid medi-
cation were not significantly associated with vertebral frac-
ture, neither was GFR nor thyroid hormone medication. A
logistic regression analyses was performed with the signifi-
cant variables from Table 3 as covariates. Treatment with
calcium in combination with vitamin D3 and bisphospho-
nates were, however, not entered in the analyses since it is
likely that the medication was given to patients with
known fractures or risk factors of fracture. The dependent
variable was a vertebral fracture (yes or no). After logistic
regression only age remained significantly associated with
vertebral fractures. Area under the ROC curve for age was
0.69, confidence interval (0.59 to 0.78).
Risk factors of thoracic vertebral fractures
Thirteen patients had one or several vertebral fractures
in L2 to L4, the area measured by DXA. Presence of
vertebral compression fractures in this location may
influence the DXA measurements. As a consequence
n e wa n a l y s e sw e r em a d ew h e r ew o m e nw i t hn ov e r t e b -
ral fractures (n = 107) were compared to women with at
least one vertebral fracture, but none in L2 to L4 (n =
30). Only patient age (P = 0.006) and DI (P =0 . 0 4 )d i f -
fered significantly between the groups. High age
remained associated with vertebral fractures in a logistic
regression, area under ROC 0.64, confidence interval
(0.53 to 0.76).
Risk factors of lumbar vertebral fracture
Women with vertebral compression fractures in the
lumbar spine (n = 15) were compared with women
without fractures in the lumbar spine (n = 135). BMD
in the total hip remained associated with lumbar frac-
ture. Area under ROC was 0.68, confidence interval
(0.52 to 0.84).
Two or more vertebral fractures
Regardless of fracture localisation (lumbar, thoracic or
both), patients with at least two vertebral fractures were
Table 2 Prevalence of vertebral fractures in female SLE patients according to age
Age Total patient number Patients with any vertebral compression Total number of vertebral compressions
Years n n (%) n
20 to 29 17 1 (6) 1
30 to 39 23 4 (17) 4
40 to 49 41 11 (26) 17
50 to 59 42 14 (33) 37
60 to 69 15 6 (40) 13
70 to 79 11 6 (54) 21
80 to 89 1 1 (100) 2
150 43 95
02468 1 0 1 2
L4
L3
L2
L1
Th12
Th11
Th10
Th9
Th8
Th7
Th6
Th5
Th4
%
Mild deformation (20 to 25% )
Moderate deformation (25 to 40%)
Severe deformation (>40%)
Figure 1 Percentage of 150 female SLE patients with
radiographic compression fractures per vertebral level. Severity
grade defined by Genant’s method.
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tic regression analyses. Both BMD in total hip and age
remained associated with prevalent fractures (two or
more). The area under ROC was 0.8, with a confidence
interval of 0.7 to 0.9.
Vertebral fractures and normal BMD
Seventeen (40%) of the patients with vertebral deformi-
ties had normal BMD in all measured locations. There
were three peripheral fractures reported from this group
which had a median of one (1 to 10) compression, med-
ian age of 47 (28 to 59) years and disease duration of 12
(2 to 41) years. Having ever used corticosteroids was
statistically equally common (P = 0.84) in women with
vertebral fractures and normal BMD 14/17 (84%) com-
pared to those with vertebral fracture and low BMD in
at least one measured location 22/26 (82%).
Discussion
Data from studies in healthy populations suggest that a
majority of vertebral compressions are subclinical [8,21].
Twenty-nine percent of the patients in our study had
at least one prevalent, radiological, vertebral compres-
sion. Eighty-eight percent of these fractures were asymp-
tomatic. This can be compared with a slightly younger
Dutch SLE population, mean age 41 years, where 20% of
the patients had at least one prevalent vertebral fracture
[22] whereas the prevalence was 21% in a premenopau-
sal cohort of SLE women in Brazil [2]. A high preva-
lence, 20.4%, of asymptomatic vertebral fractures was
also found in Chinese women with SLE [23]. The major-
ity of compressions recorded in our study were mild and
located in the thoracic spine confirming previous results
in SLE studies [22] and in studies on post-menopausal
women, with other inflammatory conditions, on long-
term glucocorticosteroid therapy [24]. In the general
population there are indications of compression frac-
tures being more abundant in the thoracolumbar
junction (Th11 to L2) [4,25]. Why fracture location
seems to differ between different populations is not
clear.
Without possibility of a direct comparison, a study on
the Swedish general population showed a 7.2% 10-year
probability of morphometric vertebral fracture in
women 50 years of age increasing to 26.8% in women
80 years of age [8]. The percentage of SLE patients with
prevalent vertebral fractures in our study increased per
decade of life from 6% in the third decade to 54% in the
eighth indicating that SLE patients are at high risk of
developing compression fractures.
Forty percent of the patients with vertebral compres-
sions in our study displayed normal BMD in all mea-
sured locations. Li et al. found that 30% of the SLE
patients with asymptomatic vertebral fracture had a nor-
mal BMD [23]. Similar results have been found in SLE
patients by Borba et al. [2] who found no BMD differ-
ence between premenopausal SLE patients with or with-
out vertebral fractures. Lee et al. [13] found that 50% of
patients with self reported fragility fractures had BMD
z-score >-1 at hip and lumbar spine whereas Yee et al.
[26] found normal BMD in few (9%) SLE patients with
self reported fragility fractures. In a Swedish study on
the general population, women with clinical vertebral
fractures had significantly lower BMD in hip, lumbar
spine and forearm compared with age-matched controls
without a history of fracture [27]. It seems that clinical
vertebral fractures more often are osteoporotic than
prevalent fractures.
We found that high age was associated with fractures
in Th4 to L4 while low BMD in total hip was a determi-
nant of fracture in the lumbar spine. Age and BMD
total hip together were strong determinants of repeated
prevalent fractures. Mendoza-Pinto et al. [28] showed
similar results in a Mexican SLE cohort, age and BMD
total hip being associated to vertebral fractures. We
believe that low total hip BMD may predict vertebral
Table 3 Comparisons between female SLE patients with and without radiological vertebral fractures
No vertebral compression (n= 107) At least one vertebral compression (n = 43)
Patient age (years) 46 (20 to 79) *** 55 (28 to 82)
Postmenopausal n(%) 49 (46) # ** 32 (76)
DI 2(0 to 8) * 3 (0 to 11)
Calcium and vitamin D n(%) 52 (49) # * 29 (67)
Bisphosphonates n (%) 10 (9) # * 11 (26)
BMD Total hip (g/cm
2) 0.94 (0.14) * 0.88 (0.16)
BMD Femoral neck(g/cm
2) 0.91 (0.14) * 0.86 (0.15)
Patients with peripheral fracture n (%) 10 (10) # ** 12 (28)
Only significant variables are shown. BMD, bone mineral density, DI, Systemic Lupus International Collaborative Clinics/American Collage of Rheumatology
Damage Index
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 vs. women with any compression fracture by t-test.
#c
2-test used to compare categorical variables.
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are several sources of error in the measurement of lum-
bar spine BMD. A false high BMD in lumbar spine can
be caused by arterial calcifications, osteoarthritis or pre-
valent vertebral compression fractures in the measured
area. Since SLE patients are at high risk of cardiovascu-
lar disease, arterial calcifications should be more pro-
nounced in a SLE cohort at a given age compared to
the general population.
Our results show that a large proportion of SLE
patients get vertebral fractures despite normal BMD.
Since some SLE patients are at high risk of thrombosis,
impaired microcirculation in bone could damage bone
cell viability and subsequently the possibility to repair
trabecular damage. Mechanisms leading to impaired
bone strength could also be initiated by autoantibodies
directed against substances necessary for healthy bone
remodelling. Frequent medication with glucocorticoster-
oids could be another explanation for fractures despite
normal BMD. It has been shown that glucocorticoster-
oids induce trabecular thinning and affect osteocyte
number and function. This could reduce vertebral com-
pression strength more at a given BMD compared to the
strength of vertebrae in aging or postmenopausal popula-
tion [7,29]. Despite the known side effects of glucocorti-
costeroids we did not find any association between
vertebral fracture and corticosteroids in our study. We
have previously described a lack of association between
glucocorticosteroids and low BMD in SLE patients [14].
One possible explanation is that systemic inflammation,
also known to accelerate bone loss, is down regulated by
corticosteroids. In a systemic inflammatory disease like
SLE, glucocorticosteroids could be beneficial regarding
bone loss in some individuals whereas it could decrease
BMD and facilitate evolvement of fracture in higher
doses or in more corticosteroid susceptible individuals.
When evaluating conventional radiographs for vertebral
compression fractures it is possible to use morphometric
or semiquantitative methods. The Genant method is a
generally accepted semiquantitative method which is used
in other SLE studies [22], studies on corticosteroid
induced osteoporosis [24] as well as recent studies on
medication against osteoporosis [30,31]. The advantage of
Genant’s method is that the radiologist adds accuracy to
the evaluation by looking for qualitative features that are
helpful in identifying fractures. Black et al. [32] have com-
pared methods for defining prevalent vertebral deformities
in osteoporosis. They conclude that patients with deformi-
ties rated as mild (grade 1) had clinical criteria and BMD
midway between patients with no fractures and those with
grade 2 or 3 fractures, indicating a continuum of vertebral
pathology. We therefore believe the used, semiquantitative
method is valid.
A limitation in our study is the absence of information
about vitamin D status in our patient cohort, a variable
of importance to bone mineralisation. Fifty-four percent
of the SLE patients were taking supplements of calcium
and vitamin D3. We therefore assume that they had no
deficiency of vitamin D3. We also lack hereditary infor-
mation of low energy fractures, information about height
reduction and data on alcohol consumption. We do not
know when the vertebral fractures have been acquired
and risk factors may therefore have changed over time.
Besides BMD there are other factors influencing the
risk of vertebral fractures such as bone dimensions,
bone and intervertebral disc quality, micro-architecture
of the bone, spine loading, and neuronal and muscle
function [33]. Whether SLE inflammation affect these or
other spine qualities in any particular way is not known.
Conclusions
Vertebral compression fractures are common but sel-
dom diagnosed in patients with SLE regardless of treat-
ment with glucocorticosteroids or not. High age and
low BMD in the total hip are the most important risk
factors associated with fracture. There may be disease-
specific factors interacting and affecting bone strength
in SLE. Therefore, in clinical guidance of which patients
should be sent to vertebral x-ray or receive anti-osteo-
porotic therapy, SLE itself should be considered to add
risk to already known general risk factors of osteoporo-
sis and fracture.
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